Vancomycin-resistant enterococcus: case reviews after transplantation.
Increased and inappropriate use of vancomycin during the past 35 years has led to the development of vancomycin-resistant enterococcal (VRE) species that are difficult and expensive to treat. This article presents case reviews of patients who experienced vancomycin-resistant enterococcus faecium (VREF) infections during prolonged hospitalizations after transplantation. The risk factors for the development of VRE infection, prevention measures, and the interventions to be implemented once VRE infection is diagnosed are discussed.
Dobbin
K R
KR
Dunworth
B A
BA
D000328:Adult; D000900:Anti-Bacterial Agents; D002985:Clinical Protocols; D003428:Cross Infection / Q000209:etiology*; D004352:Drug Resistance, Microbial; D016984:Enterococcus faecium; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000209:etiology*; D006801:Humans; D017053:Infection Control; D008297:Male; D008875:Middle Aged; D016377:Organ Transplantation / Q000009:adverse effects*; D014640:Vancomycin
D000900:Anti-Bacterial Agents; D014640:Vancomycin